Curcuma longa extract improves serum inflammatory markers and mental health in healthy participants who are overweight: a randomized, double-blind, placebo-controlled trial
Background The dietary spice Curcuma longa , also known as turmeric, has various biological effects. Both a water extract and a supercritical carbon dioxide extract of C. longa showed anti-inflammatory activities in animal studies. However, the anti-inflammatory effect in humans of a mixture of thes...
Saved in:
Published in | Nutrition journal Vol. 20; no. 1; p. 91 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
13.11.2021
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1475-2891 1475-2891 |
DOI | 10.1186/s12937-021-00748-8 |
Cover
Summary: | Background
The dietary spice
Curcuma longa
, also known as turmeric, has various biological effects. Both a water extract and a supercritical carbon dioxide extract of
C. longa
showed anti-inflammatory activities in animal studies. However, the anti-inflammatory effect in humans of a mixture of these two
C. longa
extracts (CLE) is poorly understood. Therefore, we investigated the effect of CLE containing anti-inflammatory turmeronols on chronic inflammation and general health.
Methods
We performed a randomized, double-blind, placebo-controlled study in healthy subjects aged 50 to 69 years with overweight. Participants took two capsules containing CLE (CLE group,
n
= 45) or two placebo capsules (placebo group, n = 45) daily for 12 weeks, and serum inflammatory markers were measured. Participants also completed two questionnaires: the Medical Outcomes Study (MOS) 36-Item Short-Form Health Survey (SF-36) and the Profile of Mood States (POMS) scale. Treatment effects were analyzed by two way analysis of variance followed by a
t
test (significance level,
p
< 0.05).
Results
After the intervention, the CLE group had a significantly lower body weight (p < 0.05) and body mass index (
p
< 0.05) than the placebo group and significantly lower serum levels of C-reactive protein (
p
< 0.05) and complement component 3 (
p
< 0.05). In addition, the CLE group showed significant improvement of the MOS SF-36 mental health score (
p
< 0.05) and POMS anger-hostility score (p < 0.05).
Conclusion
CLE may ameliorate chronic low-grade inflammation and thus help to improve mental health and mood disturbance.
Trial registration
UMIN-CTR, UMIN000037370. Registered 14 July 2019,
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000042607 |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1475-2891 1475-2891 |
DOI: | 10.1186/s12937-021-00748-8 |